Primary dysmenorrhoea. Primary dysmenorrhoea
Conditions
Interventions
Intervention 1: Intervention first group: valerian capsules 350 mg every 8 hours one number, the first three days of the menstrual cycle in two consecutive. Intervention 2: The second group interventi
Treatment - Drugs
Placebo
Intervention first group: valerian capsules 350 mg every 8 hours one number, the first three days of the menstrual cycle in two consecutive
The second group intervention: Ginger capsules 250 mg every 8 hours one, the first three days of the menstrual cycle in two consecutive
The control group. Placebo: capsules 250 mg of sugar per 8 hours one, the first three days of the menstrual cycle in two consecutive
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 30 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria are: single, aged 20 to 30 years, onset of menses before age 20, have regular menstrual cycles every 21-35 days, without passing clots menstrual bleeding (bleeding in mild to moderate), onset and duration of pain periods of up to several hours before day 5 of menstrual bleeding. Non-inclusion criteria included: 20 years after the onset of menstruation, known cases of chronic diseases (diabetes, hypothyroidism and less hyperthyroidism), gastric ulcer or duodenal ulcer, anticoagulation. Having symptoms such as burning, itching, abnormal discharge, history of allergy to medicinal plants, stressors such as parental divorce, death of a relative degree of two months, forced medication or special diet, smoking, history of pelvic inflammatory disease , myoma and pelvic tumors, surgery, women's history (including any open surgery and laparoscopy or laparotomy-related diseases in women, such as cysts, tumors, pelvic adhesions), transfer, transportation, or other visitors to the University and graduating within 6 next month. Criteria considered for exclusion from the study include: Samples tend to withdraw from the study, Irregular use of medication or placebo, Occurrence of any significant stress listed in the questionnaire (first degree family members died, ...) during the study,Catching any disease With prolonged use of drugs and supplements and vitamins,Performing any type of surgery during the study,married during the study ,Change the location and do not complete the questionnaire.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of pain. Timepoint: Before the intervention, two months after the intervention. Method of measurement: Day.;Pain Intensity. Timepoint: Before the intervention, two months after the intervention. Method of measurement: Wong-Baker Faces Pain Rating Scale.;Intensity of symptoms with dysmenorrhea. Timepoint: Before the intervention, two months after the intervention. Method of measurement: Verbal scale Anthresh - Mylsum. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDavoodabady Farahani Masoumeh
Arak University of Medical Sciences
Outcome results
None listed